✨ Your Portfolio is fetched and updated from zerodha.
Small Services

Sun Pharma Advanced Research Company Ltd.

SPARC

Market Cap
₹5,100 Cr.
P/E
0.00

Sun Pharma Advanced Research Company Ltd.

Key Ratios

Edit Ratio's
Market cap
Market cap
5,100 Cr
PE
PE
-
Prom Holding
Prom Holding
65.67 %
ROE (%)
ROE (%)
-307.91
ROCE (%)
ROCE (%)
-154.85
Div Yield (%)
Div Yield (%)
-
Sales
Sales
71.77 Cr
OPM (%)
OPM (%)
-450.24 %
Debt to Equity
Debt to Equity
0.37
View more
Edit Ratio's
About
SPARC is a clinical stage bio-pharmaceutical company dedicated to enhancing patient care world… Read more
Low
109
52W Range
High
253
  • Sun Pharma Adv. Res
  • Dishman Carbogen Amc
  • Zenotech Laboratorie
  • TJI Pharma - Small Cap

Timeline

Dividend Update Board Meeting Financials

Key company specific updates

Company Timeline

Subscribe now for more updates
Custom financial statementNew
Edit rows
Forensics

5 Yes

Positive for this company

2 Neutral

Neutral for this company

9 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

    locked
    Select a Metric
    • R&D as a % of Total Sales (%)
      Source
    Peer Comparison
    Corporate Actions
    Consolidated
    DATE
    DETAILS
    Show More
    Show Less
    Show More
    Show Less
    FAQs on Sun Pharma Advanced Research Company Ltd. Business

    SPARC is a clinical stage bio-pharmaceutical company specializing in pharmaceutical research and development to create innovative therapeutics and drug delivery systems for enhancing patient care globally.

    Sun Pharma Adv. Res major competitors are Dishman Carbogen Amc, Zenotech Laboratorie, Vivo Bio Tech, Jeevan Scientific, Syngene Internation., Suven Life Sciences, Hikal.
    Market Cap of Sun Pharma Adv. Res is ₹5,100 Crs.
    While the median market cap of its peers are ₹4,169 Crs.

    Sun Pharma Adv. Res seems to be less financially stable compared to its competitors.
    Altman Z score of Sun Pharma Adv. Res is 5.44 and is ranked 4 out of its 8 competitors.

    View FAQ's On Shareprice
    Company Filing
    2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
    Annual Report FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
    Earnings Release Mar Jun Dec Sep
    Investor Presentation Sep Jan Sep Nov Dec Sep Oct Sep Dec Jun Jun Sep Jun Jun Jun Dec Mar Jun Sep Dec
    Conference Call Mar Mar Jun Sep Dec Jun Sep Dec Sep Sep Sep Jun Jun Jun Mar Dec Jun
    Conference Call SummaryCon Call Summary
    Discussions & Analysis
    Sun Pharma Advanced Research Company Ltd.
    Interview With Dilip Sanghvi, Managing Director - Sun Pharmaceutical Samir Mehta, Chairman - Torrent Pharma - Flame University
    Pharmaceutical Sector
    How The Pharma Industry Works - PPFAS
    Deep Dive into Pharma Sector - Omkara Capital
    Pharma Compliance In-Depth - Amit Rajan
    Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar
    Nutraceuticals- Industry Overview - Value Educator
    Generic Opportunity for Indian Pharma Companies - Anish Moonka
    Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC
    Ideas Dashboard
    Timeline
    Watchlist
    Portfolio
    Alerts
    Research
    Stock Screener
    Market
    Raw Material